Newspaper publication for extension of issue closing date and extension of date of on market renunciation of Rights Entitlements.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Dr Lalchandani Labs Limited has published newspaper advertisements in Financial Express (English) and Jansatta (Hindi) on February 17, 2026, informing shareholders about an extension of the closing date of its ongoing Rights Issue and a corresponding extension of the last date for on-market renunciation of Rights Entitlements. The filing is a regulatory disclosure submitted to BSE (Scrip Code: 541299) attaching copies of the published advertisements. The document itself does not state the original or revised closing dates — those details would have appeared in the newspaper ads. Signed by Managing Director Arjan Lal Chandani (DIN: 07014579).
Shareholders who have not yet subscribed to or renounced their Rights Entitlements get more time to act. The extension may improve participation in the rights issue, but the lack of disclosed new dates in this filing limits immediate clarity — investors should check the newspaper ads or company website for revised timelines.